Pituitary

Papers
(The TQCC of Pituitary is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study117
Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland49
Predictors of biochemical remission after transsphenoidal surgery in a large cohort of acromegaly patients42
A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours35
The impact of facility type and volume on treatment and overall survival in craniopharyngioma34
Correction to: Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies33
Prevalence and risk factors of colon polyps and other colonic lesions in acromegaly: Insights from colonoscopy screening32
Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life32
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours31
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas28
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency28
Pituitary: hic manebimus optime26
Gigantism: microsurgical treatment by transsphenoidal approach and prognostic factors25
The assessment of thiol-disulfide homeostasis and ıschemia-modified albumin levels in patients with acromegaly23
Genetic models of Cushing’s disease22
Evaluating pituitary tumor management: aligning with pituitary tumor centers of excellence criteria22
Functioning gonadotroph adenomas in premenopausal women: clinical and molecular characterization and review of the literature21
Hospital frailty risk score predicts postoperative outcomes after endoscopic endonasal resection of non-functioning pituitary adenomas21
Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery21
Machine learning as a clinical decision support tool for patients with acromegaly20
Pituitary metastases: a case series and scoping review20
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants20
ACRODAT and SAGIT for the assessment of disease activity in acromegaly: a multicenter study of the Veneto region in Italy20
Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging‑derived texture features19
Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery19
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience19
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome18
Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre17
Radiological evolution of autograft fat used for skull base reconstruction after transsphenoidal surgery for pituitary adenomas17
Psychiatric morbidity in acromegaly: a cohort study and meta-analysis of the literature16
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors16
A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus)16
Correction: Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders16
Cushing’s disease and bone15
Commentary: The updated European society of endocrinology clinical practice guideline for the management of aggressive pituitary tumors and pituitary carcinomas15
Medical management pathways for Cushing’s disease in pituitary tumors centers of excellence (PTCOEs)15
Diagnosis of growth hormone deficiency: searching for Consensus along life15
IGF-1 is positively associated with BMI in patients with acromegaly15
Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT® using the simulated person approach14
Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes14
TSH-secreting pituitary adenomas and bone14
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation14
The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions14
Outcomes in surgical management of microprolactinomas: an international multi-institutional series13
Response to letter to the editor “Hypopituitarism and COVID-19, what else?”13
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)13
Clinical, surgical, and endocrine outcome following treatment of posterior pituitary tumors: a retrospective cohort study13
Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly13
Acromegaly is associated with a distinct oral and gut microbiota13
Clinical presentation, predictive factors and management of patients with Nelson syndrome: a retrospective study12
Reappraising prediction of surgical complexity of non-functioning pituitary adenomas after transsphenoidal surgery: the modified TRANSSPHER grade12
Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome12
Development and validation of clinical screening systems for Cushing disease in the United States12
Pituitary surgery and COVID12
Generating novel pituitary datasets from open-source imaging data and deep volumetric segmentation12
Is diabetes with acromegaly for life?12
Clinical and prognostic implications of pituitary macroadenomas (PitNets) grading: a monocentric experience11
Long COVID and pituitary dysfunctions: a bidirectional relationship?11
Copeptin after pituitary surgery: is it worth measuring?11
Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas11
Serum biomarkers of colonic polyps in patients with acromegaly: a meta-analysis and systematic review11
The clinicopathological PANOMEN-3 classification predicts pituitary adenoma prognosis: a real-world retrospective single center study of a surgically treated cohort11
[68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort11
Headache in patients with non-functioning pituitary adenoma before and after transsphenoidal surgery – a prospective study10
Serum IGF-1 May be less reliable when assessing the GH-IGF-1 axis in the elderly10
Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcome10
Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis10
Mortality in patients with dopamine agonist-treated hyperprolactinemia: a large matched-cohort study10
Characterization of a paradoxical post-operative increase in serum cortisol in Cushing disease10
Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese 10
SAGIT®, ACRODAT®, PANOMEN 3… time to implement tools for management of acromegaly..?10
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis10
Prevalence and evolution of hypertension in a large Iberian cohort of patients with acromegaly10
Effect of antineoplastic drug therapies on carcinoma and aggressive pituitary tumors: a systematic review and meta-analysis10
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults10
Refractory nonfunctioning pituitary adenomas10
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma9
Diffusion-weighted imaging does not seem to be a predictor of consistency in pituitary adenomas9
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon9
Skeletal fragility in pituitary disease: how can we predict fracture risk?9
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States9
Alert: misinformation that may hurt patients with both adrenal insufficiency and AVP deficiency9
Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans9
Surgical treatment of cystic pituitary adenomas: literature-based definitions and postoperative outcomes9
Outcomes of stereotactic radiosurgery in nelson’s syndrome: a systematic review and Meta-Analysis9
Correction: consensus on criteria for acromegaly diagnosis and remission9
Changes in pituitary adenoma patient presentation and outcomes during the COVID pandemic at a Pituitary Center of Excellence9
Posterior hypothalamic involvement on pre-operative MRI predicts hypothalamic obesity in craniopharyngiomas9
Importance of 24 h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findings9
Genetic evaluation of pediatric pituitary adenomas and USP8-related genotype-phenotype correlations in Cushing’s disease9
Measuring pituitary tumor volume: a comparison of the simplified and non-simplified ellipsoid equation with the 3D planimetric volume assessment9
Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists9
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma9
Giant prolactinomas, a detailed analysis of 196 adult cases8
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours8
The diagnosis of GH deficiency in adult β-thalassemic patients: are two different stimulation tests necessary to improve specificity?8
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency8
The effect of growth hormone replacement therapy on craniopharyngioma recurrence: a systematic review and meta-analysis8
HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency8
An update on, and genetics of refractory adenomas of childhood8
0.25301909446716